Distinct toxicity profiles for anti-BCMA myeloma therapiesDecember 12, 2023Multiple MyelomaCellular Therapy
CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases?December 11, 2023Cellular TherapyB Cell LymphomaMixed TopicsT Cell Lymphomas
This test may guide AML therapy for Black pediatric patientsDecember 11, 2023AMLGene TherapyDiversity in Medicine
Relapsed DLBCL: With Complete Interim Response, SCT Outperforms CAR TDecember 11, 2023DLBCLTransplantB Cell LymphomaMixed TopicsCellular Therapy
FDA approves first 2 gene-editing therapies for sickle cellDecember 8, 2023Gene TherapyBleeding Disorders
FDA greenlights iptacopan to treat paroxysmal nocturnal hemoglobinuriaDecember 6, 2023Bleeding Disorders
Hematology is in the Brodsky family’s bloodDecember 6, 2023Mixed TopicsCMLBleeding DisordersTransplantThrombosisAnemiaMyelodysplastic Syndrome
ASH 2023: Equity, Sickle Cell, and Real-Life OutcomesDecember 4, 2023Mixed TopicsBleeding DisordersAMLThrombosisTransplantMultiple MyelomaMyelodysplastic Syndrome
FDA approves pirtobrutinib for previously treated CLL/SLLDecember 4, 2023CLLMantle Cell LymphomaMixed TopicsNon-Hodgkin LymphomaIndolent LymphomaB Cell Lymphoma
Small-volume blood sample tubes may reduce anemia and transfusions in intensive careDecember 1, 2023Transfusion Medicine